Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Instructions to Safeguard Your Speculations In the midst of Changing Disc Rates - 24 injured in shooting at North Carolina tree lighting ceremony
- 3Phonetic Associations: A Survey of \Interfacing Worldwide People group\ Language Trade Application
- 4Vote in favor of your #1 sort of juice
- 5What's Your #1 Pizza Beating Mix?
- 6 Exercises to Anticipate in 2024
- Mosquitoes carrying malaria are evolving more quickly than insecticides can kill them – researchers pinpoint how
- Toyota Reports 2.3% Sales Drop as China Weakness Deepens
- How to get rid of your Christmas tree — and the 1 thing to never, ever do with it
- Vote In favor of Your Favored Kind Of Organic product
- Instructions to Grasp the Innovation Behind 5G Pinnacles\
- Figure out how to Perceive Warnings while Looking for an Auto Collision Lawyer
- Coalition led by Iraqi PM al-Sudani wins parliamentary elections
- Nutrient Rich Organic products: Lift Your Wellbeing
